Imaging gene–substance interactions: The effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward
Kirsch P, Reuter M, Mier D, Lonsdorf T, Stark R, Gallhofer B, Vaitl D, Hennig J (2006)
Neuroscience Letters 405(3): 196-201.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Kirsch, Peter;
Reuter, Martin;
Mier, Daniela;
Lonsdorf, TinaUniBi;
Stark, Rudolf;
Gallhofer, Bernd;
Vaitl, Dieter;
Hennig, Jürgen
Erscheinungsjahr
2006
Zeitschriftentitel
Neuroscience Letters
Band
405
Ausgabe
3
Seite(n)
196-201
ISSN
03043940
Page URI
https://pub.uni-bielefeld.de/record/2985414
Zitieren
Kirsch P, Reuter M, Mier D, et al. Imaging gene–substance interactions: The effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neuroscience Letters. 2006;405(3):196-201.
Kirsch, P., Reuter, M., Mier, D., Lonsdorf, T., Stark, R., Gallhofer, B., Vaitl, D., et al. (2006). Imaging gene–substance interactions: The effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neuroscience Letters, 405(3), 196-201. https://doi.org/10.1016/j.neulet.2006.07.030
Kirsch, Peter, Reuter, Martin, Mier, Daniela, Lonsdorf, Tina, Stark, Rudolf, Gallhofer, Bernd, Vaitl, Dieter, and Hennig, Jürgen. 2006. “Imaging gene–substance interactions: The effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward”. Neuroscience Letters 405 (3): 196-201.
Kirsch, P., Reuter, M., Mier, D., Lonsdorf, T., Stark, R., Gallhofer, B., Vaitl, D., and Hennig, J. (2006). Imaging gene–substance interactions: The effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neuroscience Letters 405, 196-201.
Kirsch, P., et al., 2006. Imaging gene–substance interactions: The effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neuroscience Letters, 405(3), p 196-201.
P. Kirsch, et al., “Imaging gene–substance interactions: The effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward”, Neuroscience Letters, vol. 405, 2006, pp. 196-201.
Kirsch, P., Reuter, M., Mier, D., Lonsdorf, T., Stark, R., Gallhofer, B., Vaitl, D., Hennig, J.: Imaging gene–substance interactions: The effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neuroscience Letters. 405, 196-201 (2006).
Kirsch, Peter, Reuter, Martin, Mier, Daniela, Lonsdorf, Tina, Stark, Rudolf, Gallhofer, Bernd, Vaitl, Dieter, and Hennig, Jürgen. “Imaging gene–substance interactions: The effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward”. Neuroscience Letters 405.3 (2006): 196-201.
Google Scholar